ATC Group: N02AA01 Morphine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N02AA01 in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N02 Analgesics
3 N02A Opioids
4 N02AA Natural opium alkaloids
5 N02AA01 Morphine

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 0.1 g
PAREN - Parenteral 30 mg
RECTAL - Rectal 30 mg

Active ingredients in N02AA01

Active Ingredient Description
Morphine

Morphine is a narcotic analgesic obtained from opium. Morphine acts as an agonist at opiate receptors in the CNS particularly Mu and to a lesser extent Kappa receptors. Mu receptors are thought to mediate supraspinal analgesia, respiratory depression and euphoria, and Kappa receptors, spinal analgesia, miosis and sedation.

Related product monographs

Title Information Source Document Type  
KADIAN Capsule extended-release FDA, National Drug Code (US) MPI, US: SPL/PLR
MORPHGESIC Controlled release tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MS CONTIN Tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
MST CONTINUS Prolonged release granules for oral suspension Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MST CONTINUS Prolonged-release tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
SEVREDOL Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
STATEX Oral Drops, Suppositories, Oral Syrup, Tablets Health Products and Food Branch (CA) MPI, CA: SPM

Medicines in this ATC group

United States (US)

Brazil (BR)

Ecuador (EC)

Finland (FI)

Germany (DE)

Hong Kong (HK)

Israel (IL)

Lithuania (LT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Romania (RO)

Singapore (SG)

Spain (ES)

Tunisia (TN)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.